IAM Magazine issue 25

August/September 2007

The CIPO manifesto

The time has come for all large corporations to appoint a chief intellectual property officer. Without a senior executive with overall responsibility for all aspects of the IP function, no company can hope to maximise the value of the rights it owns

Features

The man with a plan

Over the last few years, IBM has been a pivotal player in the development of the patent system and in exploring the financial possibilities it offers. Now Big Blue’s top IP lawyer is at it again

A different vision for patents in Europe

The European Patent Conference was launched by the FFII, a group best known for taking a hard line against software patents. By bringing different stakeholders together, the hope is that dialogue will replace confrontation as a way to build an effective European patent system

Obviousness after KSR v Teleflex: a corporate perspective

Although there was something for everyone in the KSRdecision, the real winners will ultimately turn out to be members of the patent bar

Obviousness after KSR v Teleflex: a private practice perspective

While many may see KSRas helpful to patent infringers, a close reading of the decision reveals that the opposite may, in fact, be the case

Intangible asset financial metrics

Indices based around rating the performance of quoted companies’ IP management and performance have been with us for a few years now. Recent research shows the returns investors in one would have enjoyed over a six month and one year period

P&G goes inside out

When the CEO of Procter & Gamble decided that 50% of the company’s products should be developed collaboratively, a new internal business group was born. Seven years on, it is ensuring the boss is getting exactly what he wants

Get ready for management commentary

It may not be worth putting intangibles on a balance sheet, but including them in management commentaries is a completely different matter

Insights

Brimelow faces challenges, but comes to office at a promising time

The new president of the European Patent Office will have her work cut out as she tackles a number of high-profile issues. If Alison Brimelow plays her cards right, however, she could find allies at the very top of Europe’s political ladder

Columns

Follow the money?

The failures of the US healthcare market are exacerbated by a lack of proper scrutiny of how VCs and other investors in the sector evaluate IP

Performance anxiety

When it comes to understanding what innovation rights such as patents mean to public company performance, CEOs are hiding in plain sight

The university’s ethical role as intellectual capitalist

In the developing knowledge economy, the traditional divides that separate universities from industry are not sustainable

Enforcing IP ethics

Those who are happy to continue infringing IP rights once the infringement becomes clear should spend some time in jail. That would concentrate minds a lot quicker than mechanisms such as treble damages

Australia even more patent-friendly after High Court decision

Owners or licensees of Australian patents can be more bullish about asserting them as they now have less concerns over invalidation than they would in many other countries

Patent analytics

Pharmaceuticals

Since first quarter 2006, most pharma companies have increased their patent portfolios. The realignment is most closely tied to differences in research intensity.

Co-published editorialManagement report

Outsourcing

There is no doubting that these days outsourcing is a multi-billion dollar business. And it is not hard to see why, as companies are in a position to save substantial amounts of money when they send out work to be done by third parties at a fraction of the amount it would cost for the same to be done in-house

Co-published editorialRoundtable

The Asian perspective

Four experts from some of the leading firms in Asia and the Pacific Rim discuss key IP issues facing their jurisdictions

Co-published editorialIndustry insight

How to keep in shape and beat the competition

As companies strive for new sources of value creation, with many turning to their patent portfolios as an asset base for exploitation, CPA’s John Pryor looks at ways to stay ahead of the competition

Close

Register for more free content

  • Read more IAM blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 82